The fresh leaves of Moringa stenopetala (family, Moringaceae) are commonly eaten as cabbage while dried leaves are used as nutritional supplement and for treating a variety of disease conditions including diabetes. The present investigation into the therapeutic potential of the leaves and seeds of the plant revealed no inhibitory effect against -glucosidase enzyme up to the concentration of 200 µg/mL but the leaves extract displayed potent DPPH (1,1-diphenyl-2picrylhydrazyl) radical scavenging effect (IC 50 , 59.5 ± 4.1 µg/mL). An activity directed fractionation and isolation procedure resulted in the identification of the major antioxidant compound as rutin and minor active component, neochlorogenic acid. Both the crude extract (0.8-200 µg/mL) and rutin (0.8-200 µM) but not neochlorogenic acid displayed a concentration-dependent protection of human pancreatic -cells (1.4E7 cells) from oxidant-induced cell death. The identification of these compounds along with their potential role in the nutritional and medicinal significance of the plant is discussed. \
Moringa oleifera (family, Moringaceae) is a deciduous tree indigenous to the sub-Himalayan region of India. Being considered as one of the most useful tree in the world, the plant is now cultivated in many tropical countries for its multipurpose uses including food, source of biofuel, and medication for a variety of disease conditions [1a] . Interestingly, the African Moringa, M. setenopetela, which is endemic to Southern Ethiopia and Northern Kenya, is also cultivated for similar multipurpose usages [1b]. As with M. oleifera, the plant is cropped for its highly nutritious leaves in Sothern Ethiopia. Commonly known as cabbage-tree or locally as aleko or shiferaw, M. stenopetala is widely used in Ethiopian and Kenyan traditional medicine for treating a range of illnesses such as, diabetes, hypertension, stomach pain, malaria, leishmaniasis, leprosy, epilepsy, diarrhea, asthma, colds, as an anthelmintic, emetic and wound healing [1c] . Both fresh leaves and dried powdered leaves of M. stenopetala are now widely sold all over the cities of Ethiopia and abroad as nutritional supplement (e.g. herbal tea) and for medicinal uses. As observed by the author during summer 2013, it also appears that there is no other local medicinal plant with comparable commercial value as M. stenopetala.
In view of the widely recognized socioeconomic importance of M. stenopetala crop in recent years, a flurry of scientific studies has been carried out to validate the claimed nutritional and medicinal values of the plant. The most common uses of the plant as antidiabetic agent has been substantiated by the demonstration of the leaves extract displaying promising effect in normoglycemic and alloxan-induced diabetic mice model [2a] . The crude ethanol extract and its polar fraction (e.g. n-butanol) have also shown to display antidiabetic activity in chronic and/or long treatment regime [2b] while other studies revealed that daily administration of the aqueous leaves extract (900 mg/kg) for six weeks have cholesterol lowering effect [2b,2c] . Although the doses used in these studies were somewhat high (300-900 mg/kg), the lack of acute toxicity at high doses [2b] and the plant already being safely used as a common food are good reasons to further investigate the plant as a potential source of medicine. . Considering the nutritional and medicinal value of M. stenopetala, the present study investigated the antioxidant activity of the plant for the first time and identified the active principles through a systematic activity-guided isolation studies. The pancreatic -cell protective potential of the plant is also discussed.
The antioxidant activity of the methanolic extract of the plant samples were tested by using the DPPH radical scavenging assay. A concentration-dependent radical scavenging effect was demonstrated for the leaves extracts while the seeds extract failed to show effect up to the highest concentration tested; 833.3 µg/mL. In order to see whether the reported antidiabetic effect of the leaves extract was mediated via inhibition of key carbohydrate digestive enzymes, an -glucosidase inhibition assay was also conducted. While the standard positive control acarbose showed activity (IC 50, 190.4 ± 24. 3 µM) consistent with previous reports [4] , both the seeds and leaves extracts failed to show detectable activity up to the maximum tested concentration of 200 µg/mL.
In order to study the nature of the active antioxidant principles of the leaves extract, solvent partitioning-based fractionation was employed. Suspension of the crude extract followed by extraction with solvents of ascending polarity yielded five fractions: petroleum ether, CHCl 3 , EtOAc, n-butanol and water. Analysis of their antioxidant activity together with the crude extract revealed antioxidant potential in the following order: EtOAc > n-butanol = crude extract > water > CHCl 3 > petroleum ether (Table 1) .
HPLC analysis of the crude extract through monitoring absorbance at dual wavelength (215 and 280 nm) revealed one predominant major peak that matches the retention value of the previously detected compound, rutin [3a, 3b] .
Quantitative analysis of all fractions for their rutin content was carried out using rutin as an external standard. The HPLC response taken as the peak area under curve was plotted against rutin concentrations. A straight line equation with r 2 value extremely close to one (0.9999) was achieved. The content of rutin analysis using GraphPad software (Prism) from three independent experiments is shown in Table 1 . In order to further analyse the correlation between rutin content in the extract/fractions and the observed antioxidant activity, a correlation graph was plotted ( Figure 1A ). It is clearly evident that a straight line with 95% confidence level could be seen for the crude extract and all fractions and except the water fraction. The latter fraction as shown in Table  1 , has the lowest level of rutin content but displayed activity far superior than the petrol and CHCl 3 fraction. This suggests that antioxidant compound(s) other than rutin is responsible for the observed activity of the water fraction. In order to resolve the highly polar compounds of the water fraction, a reverse phase silica gel system was employed using the fast Combiflash chromatography system. The most active fraction (F, see experimental section) was pure rutin (23 mg) while the second active fraction was a mixture that was further separated by HPLC system to yield neochlorogenic acid (75 mg). The identification of the compounds were based on spectroscopic analysis, primarily by 1D ( 1 H, 13 C and DEPT) and 2D NMR (HMQC, HMBC and COSY) and mass spectrometry. Exposure of cultured human pancreatic -cells to H 2 O 2 resulted in a concentration-dependent reduction in cell viability. In one classical experiment of the 24 h assay with 0.35, 0.7 and 1.4 mM H 2 O 2 , cell viability was reduced to 58.4 ± 3.1, 55.4±7.1 and 24.6 ± 2.3 (mean and SEM values, n=4) respectively. Treatment of cells by the crude ethanolic extract of leaves of M. stenopetala and its major component, rutin, resulted in a concentration-dependent inhibition of the H 2 O 2 -induced pancreatic -cells cell death while similar treatment with neochlorogenic acid did not result in significant cytoprotection up to the highest concentration (200 µM) tested ( Fig  1B) .
Diabetes and its complications have been shown to be directly associated with oxidative damage suggesting the potential beneficial effect of antioxidant compounds for these diseases [6a] . Since the leaves of M. stenopetala are also used as food and nutritional supplements, the demonstrated antioxidant activity has implications for combating diabetes and a variety of other oxidative-stress associated diseases.
In support of the most prominent medicinal uses of M. stenopetala leaves as antidiabetic agent, some preliminary animal studies have already revealed hypoglycaemic effect for the water and alcohol extracts [2a, 2b] . One of the mechanisms for the reported antidiabetic action of the plant could be a direct effect on key carbohydrate digestive enzymes. The present study however showed no -glucosidase activity that would be of interest to pursue further studies in these target areas. Some authors however have shown enzyme inhibitory activity of this plant at exceptionally high doses (milligram concentrations) [6b] that would not reflect therapeutic significance.
Rutin was previously detected from M. stenopetala [3a, 3b] but its quantification was based on a plant growing in the green house in the UK. In fact the reported amount was 3 mg per gram weight (0.3%), which was far smaller than the present finding. To date, rutin has been shown to have antiglycemic effect in streptozotocin model of animal diabetes [7a-7g] . In this experimental model of diabetes, rutin has also demonstrated to alter abnormalities in lipid profile as well as many other blood parameters and major organ functions including the liver, heart and the kidney [8a-8c] . Other pharmacological activities of rutin (1) relevant to diabetes therapy are its potential to inhibit diabetes nephropathy both in vitro and in vivo [8c,8d]; neuroprotective effect [8e]; anti-inflammatory effect [8f,8g] along with improvement in the antioxidant status of diabetic animals [8h] and antiglycation effect [8i] that is associated with late stage diabetes. Our previous studies has demonstrated that rutin (1) at therapeutically relevant concentrations did not display anti-αglucosidase enzyme activity [4] and only millimolar and submillimolar concentrations display inhibitory effects [9a,9b] . The finding of M. stenopetala leaves extract, that predominantly contain rutin, with no α-glucosidase activity in the present study was thus in line with previous reports. Although the direct carbohydrate digestive enzymes inhibitory activity of rutin could not be demonstrated in vitro, an in vivo effect is possible as rutin's hydrolysis product (quercetin) possess enzyme inhibitory activity [4,9c] . Rutin could thus be the major active principle of M. stenopetala that account both for antioxidant and antidiabetic effect of the plant. The minor antioxidant compound, neochlorogenic acid Antioxidant and antidiabetic potential of Moringa stenopetala Natural Product Communications Vol. 10 (3) 2015 477 along its isomer chlorogenic acid, is also known in the literature to display antidiabetic effect through various mechanisms [6a] .
The deletion of pancreatic -cells is regarded as the primary cause of type 1 diabetes while in type 2 diabetes, an increased apoptotic rate of -cells has been common even in prediabetic cases. Among the various causes of -cells death known to date are glucotoxicity, lipotoxicity, insulin resistance, inflammation, oxidative stress and/or apoptosis, an amelioration of islet blood flow and/or favorable changes in cation balance within the islets [10a] . Hence, protection of -cells death is regarded as beneficial in reversing or stopping the deterioration of diabetes pathology [6] . In line with previous studies that demonstrated human pancreatic -cells to be incredibility resistant to the toxicity of streptozotocin; we failed to detect toxicity to this agent in vitro up to the concentration of 1000 µg/mL (data not shown). Hence, an in vitro model of oxidative damage induced by H 2 O 2 [10b-10d] was utilized in the present toxicity studies. Using this model, it is shown here for the first time that M. stenopetala extract and its major active constituent, rutin, can protect the human pancreatic -cells, 1.4E7 cells, from oxidative damage and/or cell death. In agreement with our finding, the active principles of M. stenopetala, rutin, has previously been shown to protect -cells from toxicity induced by oxidants [8i]. Neochlorogenic acid, however, failed to protect cells up to the highest concentration tested (200 µM).
In conclusion, the present study investigated the antioxidant and antidiabetic potential of the highly sought after African nutritional and medical plant, M. steonpetala. Activity directed-fractionation study revealed the major active principles as rutin and minor component as neochlorogenic acid. The study for the first time provided direct evidence into the potential nutritional value and antidiabetic potential of M. stenopetala components.
Experimental
General: Acarbose, DPPH, 5,5-dithiobis [2-nitrobenzoic acid] (DTNB), hydrogen peroxide (H 2 O 2 ) yeast α-glucosidase (from Saccharomyces cerevisiae, 0.5 U/mL), p-nitrophenyl-α-Dglucopyranoside (pNPG), standards chlorogenic acid and neochlorogenic acid, sodium carbonate and streptozotocin were purchased from Sigma (Sigma-Aldrich Chemical Company, Dorset, UK). HPLC solvents and other reagents were obtained from Fisher Scientific UK Ltd (Loughborough, UK). Alamar Blue TM was a product of Serotec (Oxford, UK). All other chemicals and reagents were of analytical grade and solutions were freshly prepared before use. 1 H NMR, 13 C NMR and 2D-NMR (COSY, NOESY, HMQC and HMBC) spectra were obtained on a JEOL 500 MHz instrument as described previously [11a] .
The High resolution mass spectroscopy instrument, Thermofisher LTQ Orbitrap XL (Thermofisher Scientific, UK), with an electrospray ionisation probe was used for accurate mass measurement.
Processing of the material: Powdered leaves and dried seeds of M. stenopetala were purchased from various areas of Ethiopian herbal shops: A farm store at the Debrezeit City (~30 miles from Addis Ababa) and three suppliers in Addis Ababa (Abadir supermarket; K Vegetable and Fruit P.L.C. and Aritiherbal Shops). Chromatography-based analysis reveals that these products were incredibly similar qualitatively and differ on quantitative appearance of their constituents (data not shown). Hence, only leaves and seeds obtained from one shop, Aritiherbal Shop (Mickey Leyland, Addis Ababa), was used in this study. Powdered leaves and seeds (100 g each) were soaked in methanol (2.5 l) for two weeks. Removal of the solvent under reduced pressure using a rotary evaporator afforded 17.3 and 6.4 g respectively of the leaves and seeds extract residues.
Fractionation of the crude extract:
A portion of the crude extract (13.5 g) was suspended in 600 mL of deionised water and successively fractionated with solvents of ascending polarity: 3 times each of 600 mL petroleum ether (yield: 2.7 g), chloroform (yield: 0.8 g) and ethyl acetate (yield: 0.2 g), n-butanol (4.8 g) and water (4.5 g).
Isolation of the antioxidant principles:
RediSep C18 gold column (100g, Presearch, Hampshire, UK) attached to a Teledyne Isco flash chromatography system was used to isolate the active principles. Briefly, a linear gradient of methanol in water was established by starting from 10% methanol to 40% over a period of 15 minutes and then raising methanol to 90% at 20 minutes. The flow rate was maintained at 60 mL/min and the chromatogram was monitored by using dual wavelength of 214 and 254 nm. The water fraction was subjected to this chromatographic condition to obtain six fractions: A (1-2min), B (2-3 min), C (3-4 min), D (4-6 min), E (6-8 min) and F (16-18 min). The most antioxidant fraction as assessed by DPPH assay was F which was identified as rutin. The second active fraction, B, was further purified by HPLC.
HPLC analysis:
An Agilent 1200 series gradient HPLC system with analytical and semi-prep scale C-18 columns and a mobile phase mixture of water (A) and methanol (B) were used essentially as described previously [11a] . The composition of the mobile phase at a flow rate of 1 mL/min was rising from 10% to 90% B over a period of 50 minutes.
DPPH radical scavenging:
The antioxidant activity of test samples was measured by using our established microtitre-based DPPH assay [11b].
α-Glucosidase inhibition assay:
Our published microtiter-based assay was adopted [4] .
Pancreatic -cell protection assay: The human pancreatic cell line, 1.4E7, of European Collection of Cell Cultures (ECACC) origin was obtained from the Public Health England (Porton Down, Salisbury, UK). Cell cultures were maintained with RPMI 1640 medium supplemented with 10% heat inactivated fetal bovine serum, 50 IU/mL penicillin and 50 μg/mL streptomycin in a humidified atmosphere of 95% air-5% CO 2 at 37°C. For -cell protection assay, cells were seeded in 96-well plates at a density of 20,000 cells per well and allowed to establish by incubating plates for 24 h. Various concentrations of the test agents were then added to cell cultures followed by (30 minutes) addition of various concentrations of H 2 O 2 to cause oxidative damage. After 24 h of incubation, Alamar Blue TM was added and cell viability measured from fluorescence intensities as described previously [10c].
Statistical analysis:
Data are presented as mean and SEM values from a minimum of four replicates and all experiments were repeated at least three times. Where appropriate, the significance of difference between two means was analyzed by using unpaired ttest.
